Pfizer filed with the SEC on May 27, 2026, regarding institutional share holdings and active buying/selling of stock.
3 reports, 2 independent
Updated Tue 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer filed with the SEC on May 27, 2026, regarding institutional share holdings and active buying/selling of stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Institutional investors made further modifications to Pfizer stock holdings.1 source
Filing required regarding institutional share holdings for Pfizer with the SEC.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Institutional investors filed holdings for the First Trust Innovation Leaders ETF with the Securities and Exchange Commission.
- The SEC is tracking 13F filings submitted by institutional investors, involving Omnicom Group.
- The SEC requires institutional investors to file 13F reports for the JPMorgan International Research Enhanced Equity ETF.
- SEC filing tracks institutional investment in TOV.
- SEC filing reports institutional investment activity for the Schwab U.S. Mid-Cap ETF.